10/29/2012 - 9:58am

Par Pharmaceutical Cos. has bought rights to a generic version of a drug used to treat bipolar disorder and schizophrenia.

10/29/2012 - 9:14am

The Food and Drug Administration has approved a Type 2 diabetes drug made by Watson Pharmaceuticals, the company said, following a federal court's order for the agency to approve the drug.

10/25/2012 - 10:10am

The Food and Drug Administration has approved a generic drug for leukemia made by a subsidiary of Par Pharmaceutical Cos.

10/24/2012 - 10:48am

Mylan is challenging a federal court decision ordering the Food and Drug Administration to allow Watson Pharmaceuticals to launch a generic diabetes drug, Mylan said.

10/23/2012 - 11:57am

The Food and Drug Administration is expected to decide at the end of this week whether to approve a new oral drug for pulmonary arterial hypertension made by United Therapeutics.

10/23/2012 - 10:52am

Cardinal Health has introduced a new multidose drug packaging system that it said would help pharmacy customers adhere to medication regimens, the company said Tuesday.

10/23/2012 - 9:50am

A federal court has ordered the Food and Drug Administration to approve a generic diabetes drug made by Watson Pharmaceuticals, the drug maker said.

10/22/2012 - 10:53am

Watson Pharmaceuticals and Actavis will have to divest rights to almost two dozen drugs as a condition for U.S. regulatory approval of their $5.6 billion merger announced earlier this year, according to regulatory documents.

10/19/2012 - 10:34am

The Food and Drug Administration has given tentative approval to a new drug for HIV made by an Indian company.